ConductScience.org, home

Paper41008918

PARP3 Promotes AML Progression via Activation of PI3K/AKT/mTOR Signaling.

Cao T and 6 others. Cancers (Basel), 2025. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. PARP3 Promotes AML Progression via Activation of PI3K/AKT/mTOR Signaling. Papers, record 41008918. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41008918

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
PARP3 Promotes AML Progression via Activation of PI3K/AKT/mTOR Signaling.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2025-09-30
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cao TTingyong
2Zhang YYurong
3Liu HHuan
4Zhang HHongbin
5Li LLiangliang
6Li XXiaoli
7Zhao LLi

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
No.25JRRA1029Gansu Province Youth Science and Technology Fund programPubMed

Source PubMed

Download CSV of grants

References49

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135562747Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations.J Hematol Oncol2022https://conductscience.org/library/papers/35562747PubMed
237272257Acute myeloid leukemia (AML)-derived mesenchymal stem cells induce chemoresistance and epithelial-mesenchymal transition-like program in AML through IL-6/JAK2/STAT3 signaling.Cancer Sci2023https://conductscience.org/library/papers/37272257PubMed
337596643PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer.Mol Cancer2023https://conductscience.org/library/papers/37596643PubMed
416924674PARP-3 associates with polycomb group bodies and with components of the DNA damage repair machinery.J Cell Biochem2007https://conductscience.org/library/papers/16924674PubMed
536109561PARP3 supervises G9a-mediated repression of adhesion and hypoxia-responsive genes in glioblastoma cells.Sci Rep2022https://conductscience.org/library/papers/36109561PubMed
638830565Enhancing cisplatin drug sensitivity through PARP3 inhibition: The influence on PDGF and G-coupled signal pathways in cancer.Chem Biol Interact2024https://conductscience.org/library/papers/38830565PubMed
727530147PARP3 is a sensor of nicked nucleosomes and monoribosylates histone H2B(Glu2).Nat Commun2016https://conductscience.org/library/papers/27530147PubMed
821211721PARP-3 and APLF function together to accelerate nonhomologous end-joining.Mol Cell2011https://conductscience.org/library/papers/21211721PubMed
935797463Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN.Blood2022https://conductscience.org/library/papers/35797463PubMed
1021270334Poly(ADP-ribose) polymerase 3 (PARP3), a newcomer in cellular response to DNA damage and mitotic progression.Proc Natl Acad Sci U S A2011https://conductscience.org/library/papers/21270334PubMed
1139189367PARP enzymes and mono-ADP-ribosylation: advancing the connection from interferon-signalling to cancer biology.Expert Rev Mol Med2024https://conductscience.org/library/papers/39189367PubMed
1225322685Dual PI3K/mTOR inhibition shows antileukemic activity in MLL-rearranged acute myeloid leukemia.Leukemia2015https://conductscience.org/library/papers/25322685PubMed
1335732831The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.Leukemia2022https://conductscience.org/library/papers/35732831PubMed
1428447610PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA.Nat Commun2017https://conductscience.org/library/papers/28447610PubMed
1532326335The PI3K-Akt-mTOR Signaling Pathway in Human Acute Myeloid Leukemia (AML) Cells.Int J Mol Sci2020https://conductscience.org/library/papers/32326335PubMed
1637803061Expression profiling of extramedullary acute myeloid leukemia suggests involvement of epithelial-mesenchymal transition pathways.Leukemia2023https://conductscience.org/library/papers/37803061PubMed
1729423093
Combination of a hypomethylating agent and inhibitors of PARP and HDAC traps PARP1 and DNMT1 to chromatin, acetylates DNA repair proteins, down-regulates NuRD and induces apoptosis in human leukemia and lymphoma cells.
Oncotarget2018https://conductscience.org/library/papers/29423093PubMed
1831623402Antileukemic Efficacy in Vitro of Talazoparib and APE1 Inhibitor III Combined with Decitabine in Myeloid Malignancies.Cancers (Basel)2019https://conductscience.org/library/papers/31623402PubMed
1930213852Parp3 promotes long-range end joining in murine cells.Proc Natl Acad Sci U S A2018https://conductscience.org/library/papers/30213852PubMed
2030039287PARP3 inhibitors ME0328 and olaparib potentiate vinorelbine sensitization in breast cancer cell lines.Breast Cancer Res Treat2018https://conductscience.org/library/papers/30039287PubMed

See all 49 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
41732388Targeting FN1 to overcome gemcitabine resistance in gallbladder cancer: Mechanistic insights and an iRGD-modified PEG-PLGA nanoparticle delivery strategy.Mater Today Bio2026https://conductscience.org/library/papers/41732388

Source PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
MTOR2475PubTator's text mininghttps://conductscience.org/library/genes/2475NCBI Gene
PARP310039PubTator's text mininghttps://conductscience.org/library/genes/10039NCBI Gene
PIK3CB5291PubTator's text mininghttps://conductscience.org/library/genes/5291NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41008918

GET https://conductscience.org/api/papers/v1/41008918/references?page=2